Woo Joo Kim

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Jung Yeon Heo

Visiting professor

McMaster University

CANADA

View details

Won Suk Choi

Associate Professor

Yonsei University College of Medicine

SOUTH KOREA

View details

Hye Seong

Yonsei University College of Medicine

SOUTH KOREA

View details

Hee Jin Cheong

Yonsei University College of Medicine

SOUTH KOREA

View details

Sehyun Shin

Professor

Korea University

SOUTH KOREA

View details

Joon Young Song

Professor

Korea University College of Medicine and School of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Woo Joo Kim

Research Interests

Explore related searches

Contact this professor

Articles (11)

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Concurrent Subacute Thyroiditis and Graves’ Disease After COVID-19: A Case Report

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study

Vaccination Rates of Hospitalized Patients at High Risk of Severe COVID-19: A Single-Center Cross-Sectional Study

Rapid Extraction of Viral Nucleic Acids Using Rotating Blade Lysis and Magnetic Beads

The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases

COVID-19 Vaccination in Korea: Past, Present, and the Way Forward

Collaborators (6)

Jung Yeon Heo

Won Suk Choi

Hye Seong

Hee Jin Cheong

Sehyun Shin

Joon Young Song

Make your next move.

Woo Joo Kim

Research Interests

Explore related searches

Contact this professor

Articles (11)

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Concurrent Subacute Thyroiditis and Graves’ Disease After COVID-19: A Case Report

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged &ge;65 Years, Adults Aged 50&ndash;64 Years, and At-Risk Adults Aged 19&ndash;64 Years

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study

Vaccination Rates of Hospitalized Patients at High Risk of Severe COVID-19: A Single-Center Cross-Sectional Study

Rapid Extraction of Viral Nucleic Acids Using Rotating Blade Lysis and Magnetic Beads

The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases

COVID-19 Vaccination in Korea: Past, Present, and the Way Forward

Collaborators (6)

Jung Yeon Heo

Won Suk Choi

Hye Seong

Hee Jin Cheong

Sehyun Shin

Joon Young Song

Make your next move.

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years